4
Changes in Ownership
ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-22-000818
President and CEO gave up 48,752 shares (to pay taxes)
- President and CEO acquired 213,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KIDRON NADAV President and CEO | 2022-01-03 | Grant or award | +150,000 | 936,481 | D: show line 1 in the form | ||
| KIDRON NADAV President and CEO | 2022-01-03 | Shares withheld for taxes | −48,752 | $13.89 | $677,165 | 887,729 | D: show line 2 in the form |
| KIDRON NADAV President and CEO | 2022-01-03 | Grant or award | +63,000 | 950,729 | D: show line 3 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| KIDRON NADAV President and CEO | 2022-01-03 | Grant or award · Stock Option (right to buy | +107,000 | 107,000 | D: show line 4 in the form |
Loading xslF345X03/ownership.xml…